论文部分内容阅读
For a long time, treatment of peritoneal metastases（PM） was mostly palliative and thus, this status was linkwith ＂terminal status/despair＂. The current multimodaltreatment strategy, consisting of cytoreductive surgery（CRS） and hyperthermic intraperitoneal